Your Gate to Latin American IP

Argentina supports Mexico’s claim at the UNSC

By Estudio Chaloupka - 25/02/2021

On February 17, 2021, Mexico denounced the unfair access to COVID-19 vaccines at a meeting of the United Nations Security Council (UNSC). In his remarks during an open debate, Mexico’s Secretary of Foreign Affairs Marcelo Ebrard stressed that the Covax vaccine coalition must accelerate vaccine distribution and reverse the hoarding by countries that have acquired three-quarters of all vaccines. COVAX is a multilateral collaboration that includes almost all of the countries in the world, co-led by Gavi, the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Health Organization (WHO). Its aim is to accelerate the development and manufacture of COVID-19 vaccines, and to guarantee fair and equitable access for every country in the world.

This week, Argentina’s President Alberto Fernández supported Mexico’s claims during an official visit to Mexico. Fernández landed in Mexico City to meet his Mexican counterpart Andrés Manuel López Obrador and visit an AstraZeneca vaccine laboratory. With the support of the private sector, Mexico has been able to do the fill/finish of the AstraZeneca vaccine in cooperation with Argentina, which will benefit all of Latin America. An agreement signed between the British pharmaceutical company and the biotechnology company mAbxience of the INSUD Group includes transfer of technology for both countries to produce 150 million doses of the vaccine to supply all of Latin America with the exception of Brazil.

The purpose of the February 17, 2021, UNSC meeting was to discuss fair access for all countries to the COVID-19 vaccines, and implementation of Security Council Resolution 2532 (2020) on the cessation of hostilities during the COVID-19 pandemic. All 15 member States attended. In his opening remarks, United Nations Secretary-General António Guterres called for more solidarity in distributing the vaccines.

The Foreign Secretary of Mexico said the pandemic has had a devastating social and economic impact throughout the world but has affected the poorest and most vulnerable countries to a greater extent. “The progress made in peacebuilding and development has been undone and vaccination campaigns have been interrupted in 45 countries with humanitarian or refugee crises,” Mr Ebrard stated. 

By Estudio Chaloupka - 25/02/2021
Subscribe to the Newsletter

Estudio Chaloupka

Estudio Chaloupka Industrial Property is a professional firm specialized in Intellectual Property, existing as of more than 50 years (under different names), with a staff of professionals with a high level of technical and legal expertise in trademarks, patents, models and industrial designs, copyright, software, licensing, domain names and litigation.

The firm provides its clients - pertaining to the fields of pharmaceuticals, chemicals including agrochemicals, banking, luxury goods, equipment and supplies for the oil industry, footwear, garments, food and drinks, hotels- with a complete range of intellectual property services not only in Argentina but also throughout the world. 

Our professional team is committed to providing clients with high quality services, tailored to their particular needs, allowing  them to achieve their professional and business goals.